Wentworth Kory James

Entrada Therapeutics, Inc. ยท Chief Financial Officer

Wentworth Kory James is listed in public filings as officer: Chief Financial Officer. This Wentworth Kory James insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Entrada Therapeutics, Inc. (TRDA). Investors use Wentworth Kory James's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Entrada Therapeutics, Inc.TRDA$1.5M119k sharesSellApr 1, 2026$32.4K2.5k shares$12.95--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Entrada Therapeutics, Inc.TRDA$1.6M121.5k sharesSellMar 10, 2026$148.2K11.4k shares$13.02--
Entrada Therapeutics, Inc.TRDA$1.7M132.9k sharesSellMar 9, 2026$66.2K5.1k shares$13.00--
Entrada Therapeutics, Inc.TRDA$1.7M138k sharesSellMar 4, 2026$97.9K8k shares$12.25--
Entrada Therapeutics, Inc.TRDA$1.7M146k sharesGrant / ExerciseMar 3, 2026$67.2K5.7k shares$11.76--
Entrada Therapeutics, Inc.TRDA$1.8M151.7k sharesGrant / ExerciseMar 2, 2026$34.3K2.9k shares$11.66--
Entrada Therapeutics, Inc.TRDA$795k66.6k sharesGrant / ExerciseMar 1, 2026$794.5K66.6k shares$11.93--
Entrada Therapeutics, Inc.TRDA--154.6k sharesGrant / ExerciseMar 1, 2026Disclosure amount unavailable44.6k shares----
Entrada Therapeutics, Inc.TRDA$1.1M110k sharesSellNov 21, 2025$88.9K8.9k shares$9.98--
Entrada Therapeutics, Inc.TRDA$646k118.9k sharesGrant / ExerciseSep 2, 2025$9.4K1.7k shares$5.43--
Entrada Therapeutics, Inc.TRDA$42k20k sharesGrant / ExerciseApr 3, 2025$23.4K11.1k shares$2.10--
Entrada Therapeutics, Inc.TRDA$1.2M109.5k sharesSellMar 17, 2025$19.0K1.8k shares$10.67--
Entrada Therapeutics, Inc.TRDA$1.3M111.3k sharesGrant / ExerciseMar 3, 2025$57.6K4.9k shares$11.68--
Entrada Therapeutics, Inc.TRDA$756k63.3k sharesGrant / ExerciseMar 1, 2025$755.8K63.3k shares$11.94--
Entrada Therapeutics, Inc.TRDA--116.2k sharesGrant / ExerciseMar 1, 2025Disclosure amount unavailable42.4k shares----
Entrada Therapeutics, Inc.TRDA$1.5M73.8k sharesSellDec 2, 2024$100.0K5k shares$20.00--
Entrada Therapeutics, Inc.TRDA$65k31.2k sharesGrant / ExerciseDec 2, 2024$10.5K5k shares$2.10--
Entrada Therapeutics, Inc.TRDA$76k36.2k sharesGrant / ExerciseNov 29, 2024$2.1K1k shares$2.10--
Entrada Therapeutics, Inc.TRDA$1.5M73.8k sharesSellNov 29, 2024$20.0K1k shares$19.97--
Entrada Therapeutics, Inc.TRDA$1.5M73.8k sharesSellNov 11, 2024$172.6K8.6k shares$19.98--
Entrada Therapeutics, Inc.TRDA$78k37.2k sharesGrant / ExerciseNov 11, 2024$12.6K6k shares$2.10--
Entrada Therapeutics, Inc.TRDA$1.1M76.5k sharesSellSep 9, 2024$47.8K3.2k shares$14.97--
Entrada Therapeutics, Inc.TRDA$1.2M79.7k sharesGrant / ExerciseSep 5, 2024$2.5K165 shares$15.13--
Entrada Therapeutics, Inc.TRDA$1.2M79.8k sharesGrant / ExerciseSep 4, 2024$14.5K941 shares$15.42--
Entrada Therapeutics, Inc.TRDA$1.4M80.8k sharesGrant / ExerciseSep 3, 2024$2.5K149 shares$16.93--
Entrada Therapeutics, Inc.TRDA$1.4M80.8k sharesGrant / ExerciseSep 3, 2024$24814 shares$17.70--
Entrada Therapeutics, Inc.TRDA$1.3M81k sharesGrant / ExerciseSep 3, 2024$7.3K462 shares$15.76--
Entrada Therapeutics, Inc.TRDA$1.2M81.4k sharesSellJul 8, 2024$26.3K1.8k shares$14.95--